SEC Form 4 · accession 0001209191-15-022736
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maria D Stahl
Officer — SVP and General Counsel
Period of report
Mar 4, 2015
Accepted (ET)
Mar 5, 2015 · 8:54 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $38.50 | Mar 4, 2015 | A | 125,000 | A | — | Mar 3, 2025 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1This option vests over four years. Twenty-five percent (25%) of the shares will vest on March 4, 2016 and 6.25% of the shares will vest at the end of each successive quarter thereafter.